Exploring Blood‐Based Biomarkers in a Comparative Study of Amyloid‐Negative and Amyloid‐Positive Clinical Alzheimer's Syndrome
These findings highlight distinct biomarker profiles between Aβ+ and Aβ- individuals, offering insights into the pathophysiology of clinical Alzheimer's syndrome.
Authors
- Carlos Roncero (ORCID: https://orcid.org/0000-0002-8712-0843)
- Cheryl L. Wellington (ORCID: https://orcid.org/0000-0001-7014-039X)
- Mari L. DeMarco
- Bruna Seixas Lima
- Durjoy Lahiri
- Howard Chertkow
- Jennifer G Cooper
Institutions
- Providence Health Care (CA)
- University of British Columbia (CA)
- University of Toronto (CA)
- Queen's University (CA)
- Baycrest Hospital (CA)
- Occupational Cancer Research Centre (CA)
- Kingston Health Sciences Centre (CA)
- Quebec - Clinical Research Organization in Cancer (CA)
- Consortium canadien en neurodégénérescence associée au vieillissement
- McGill University (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101554
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00